Regulation & Approvals
Endava Receives NYSE Notice Over Late Form 20-F, Has Six Months to Regain Compliance
By News Desk ·
Key takeaways
- Endava received an NYSE notice for failing to file its fiscal 2026 Form 20-F by the November 17, 2026 due date.
- Endava has six months to file the report and regain compliance, and trading is not immediately affected.
- Endava's preliminary revenue adjustment estimate is approximately 2%–4% of fiscal 2025 revenue, and management is discussing potential impact with lenders.
Endava received an NYSE notice for failing to file its fiscal 2026 Form 20-F by the November 17, 2026 due date, TradingView reported. The company has six months to file the report and regain compliance, and trading is not immediately affected. Endava's preliminary revenue adjustment estimate remains approximately 2%–4% of fiscal 2025 revenue.
Endava's Six-Month Filing Window
Endava is a UK-headquartered IT services and digital transformation company serving enterprise and mid-market clients across 14 verticals, primarily finance, payments, healthcare, retail, and insurance, through an AI-native delivery platform. The NYSE notice creates a defined deadline for the company to file its fiscal 2026 Form 20-F and return to compliance. The release says listing and trading are not immediately affected.
The filing delay follows an investigation that identified revenue recognition errors, which prompted a restatement. The preliminary revenue adjustment estimate of approximately 2%–4% of fiscal 2025 revenue reflects that restatement. Management is discussing the potential impact with lenders, and the release provides no quantified impact on the revolving credit facility.
The NYSE notice is a compliance step rather than a delisting action. Other NYSE issuers have faced delisting proceedings in recent days: the NYSE suspended trading of Accendra Health common stock effective November 16, 2026, and began delisting proceedings over abnormally low selling prices, according to TradingView.
Endava's Revenue Base Behind the Adjustment
According to akta.pro company records, Endava reported £178.5 million in Q3 FY2026 revenue for the quarter ended March 31, 2026, an 8.4% year-over-year decline. The company's full-year FY2026 revenue guidance was £721.8–725.8 million, lowered from original guidance of £736–750 million. The preliminary revenue adjustment estimate is approximately 2%–4% of fiscal 2025 revenue.
Endava's Accounting Disclosures Before the Notice
A securities fraud class action filed by Glancy Prongay Wolke & Rotter LLP in September 2026 alleged false statements about accounting treatment of customer and supplier agreements, according to FinancialContent Business Page. Endava's disclosures on October 28 and November 3, 2026 preceded the NYSE notice. Analysts projected $0.16 per share and $241.86 million in revenue for the Q4 2026 earnings announcement expected on November 10, 2026, American Banking and Market News reported.
Endava's Next Filing Steps
Endava has six months from the notice to file its fiscal 2026 Form 20-F and regain compliance. The company faces a November 30, 2026 deadline for lead-plaintiff status in the securities class action, American Banking and Market News reported.